Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer : preplanned cost-effectiveness analysis of the JFMC37-0801 study
Year of publication: |
2022
|
---|---|
Authors: | Shibahara, Hidetoshi ; Shiroiwa, Takeru ; Ishiguro, Megumi ; Nakamura, Masato ; Hasegawa, Junichi ; Yamaguchi, Shigeki ; Masuda, Yuriko ; Sakamoto, Junichi ; Tomita, Naohiro ; Fukuda, Takashi |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 23.2022, 7, p. 1159-1171
|
Subject: | Adjuvant chemotherapy | Capecitabine | Colon cancer | Cost-effectiveness | JFMC37-0801 study | Krebskrankheit | Cancer | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | EU-Staaten | EU countries |
-
Sun, Li, (2024)
-
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
Jongeneel, Gabrielle, (2020)
-
Gulliford, Martin C., (2014)
- More ...
-
Shiroiwa, Takeru, (2010)
-
Shiroiwa, Takeru, (2010)
-
Shiroiwa, Takeru, (2009)
- More ...